Tesamorelin Product Information
Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) developed for use in laboratory and preclinical research settings. It is structurally designed to interact with GHRH receptors associated with pituitary somatotroph signaling pathways in non-human test subjects. This receptor interaction is examined in research models to evaluate endogenous growth hormone (GH) signaling mechanisms and downstream pathway activity under controlled experimental conditions. Tesamorelin includes an N-terminal hexenoyl modification, which has been studied for its effects on molecular stability and receptor interaction characteristics in analytical environments. Within non-human laboratory models, Tesamorelin is utilized to investigate endocrine signaling behavior, peptide-receptor dynamics, and metabolic pathway responses associated with GHRH-mediated activity. Its defined structural properties and characterized pharmacokinetic profile support its use as a reference compound in studies examining hormone signaling systems and regulatory pathway modeling under standardized research conditions. Summary of Characteristics Characteristic Details Chemical Sequence of Amino Acids Tyr-D-Ala-Ala-Asn-Leu-Ser-Ser-Val-Thr-Gln-Glu-Phe-Arg-Lys-Ala-Leu-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Glu-Gln-Thr-Leu-Leu-Glu-Glu-Ala-Phe-Thr-Gly-Ser-Pro-Arg-Ala-Hexenoyl Molecular Formula C221H366N72O67S Molecular Weight 5,135.85 g/mol CAS Number 218949-48-5 Other Known Titles GHRH analog (research designation)
